MN1 proto-oncogene (MN1) (C-Term) Peptide
MN1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN980166
Quick Overview for MN1 proto-oncogene (MN1) (C-Term) Peptide (ABIN980166)
Target
Meningioma 1 (MN1)
(MN1 proto-oncogene (MN1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- EKAKPQNPNS KEAHDLPANK ASASQPGSHL QCLSVHCTDD VGDAKARASV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MN1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Background
-
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.
Alias Symbols: MGCR, MGCR1, MGCR1-PEN, dJ353E16.2
Protein Interaction Partner: EP300
Protein Size: 1320 -
Molecular Weight
- 136 kDa
-
Gene ID
- 4330
-
NCBI Accession
- NM_002430, NP_002421
-
UniProt
- Q10571
Target
-
You are here:
